BioNTech SE - ADR vs Clear Secure Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Clear Secure Inc trades at $48.19 (market cap $4.98B). The key difference: BioNTech SE - ADR is far larger — about 4.7× Clear Secure Inc's market cap, and Clear Secure Inc pays a 1.19% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | YOU | |
|---|---|---|
Market Cap | $23.31B | $4.98B |
Sector | Health | Technology |
52-Week High | $119.34 | $62.36 |
52-Week Low | $83.89 | $29.61 |
Enterprise Value | $6.60B | $4.13B |
Dividend Yield | — | 1.19% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →